Shuoyang, China — A deadly explosion at a biotech company in northern China claimed the lives of eight individuals early Saturday morning, state-run media reported on Sunday. The incident took place in the Shanxi province, where dark yellow smoke was seen rising from the site of the blast.
Emergency responders arrived quickly at the scene, located in a mountainous area approximately 40 kilometers from the nearest town center, Shanyin. Eyewitnesses described the alarming sight of smoke billowing from the facility, raising concerns about potential risk to surrounding communities.
Authorities have detained the legal representative of Jiapeng Biotechnology, the company involved in the blast, as part of a broader investigation into the incident. The local government has formed an investigative team to determine the cause of the explosion and assess safety protocols at the facility.
Initial reports suggest that Jiapeng Biotechnology was not authorized to manage hazardous materials, raising questions about safety oversight and regulatory compliance. Established on June 26, the firm operates near a village that was previously a mining site, an area not typically known for biotech activities.
Concerns about workplace safety in China’s private sector have been heightened following similar incidents in recent years, prompting calls for stricter regulations and enforcement. The lack of a website for Jiapeng Biotechnology has also drawn attention, as it complicates efforts to gather information about the company and its activities.
Officials have yet to provide further details regarding what may have caused the explosion, which continues to spark alarm among the local population. As investigators dig deeper into the circumstances surrounding the tragedy, many are left wondering about the implications for nearby residents and the biotech industry as a whole.